UK and Chinese researchers unlocked the genomic sequence of Scutellaria barbata (barbed skullcap), identifying how it produces scutebarbatine A, a compound active against cancer cells but not non-cancer cells. The study, published in Molecular Plant, highlights its potential for developing new anti-cancer drugs from traditional Chinese medicine. Clinical evidence supports its use in reducing metastatic tumors during chemotherapy.

A randomized controlled trial published in Nutrients found that a Scutellaria lateriflora extract supplement improved sleep quality in insomnia patients, with effects persisting after discontinuation. The 400 mg daily dose over 56 days enhanced sleep-wake cycles and quality of life. This supports skullcap's role in US health trends for natural sleep aids.

A recent study demonstrates that a formulation including Chinese Skullcap (Scutellaria baicalensis) enhances stress reduction, mood, sleep quality, and cognition. This aligns with US health trends toward herbal supplements for mental wellness. Published in a peer-reviewed context, it underscores skullcap's growing role in dietary supplements.